NCT02237534View on ClinicalTrials.gov

Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia

PHASE4UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2023

Study Completion Date

September 30, 2023

Conditions
Renal Insufficiency, ChronicHyperphosphatemiaBone Diseases, Metabolic
Interventions
DRUG

Lanthanum carbonate

DRUG

Calcium Carbonate

Trial Locations (1)

565-0871

Osaka University Hospital, Suita

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Osaka University

OTHER